Hepatitis B Virus Reactivation Induced by Infliximab Administration in a Patient with Crohn’s Disease

Table 1

Laboratory data on admission.

Urine			BUN	12.4	mg/dL
Protein	(−)		Creatinine	1.34	mg/dL
Sugar	(−)		Na	136	mEq/L
Blood	(−)		K	4.3	mEq/L
Urobil.	(±)		Cl	105	mEq/L
			Ca	8.1	mg/dL
WBC	4300	/μL	Amylase	169	IU/L
RBC	359×10^4	/μL
Hb	11.5	g/dL	CRP	3.75	mg/dL
Ht	33.1	%
Platelet	20.1×10^4	/μL	PT	89.1	%
			PT (INR)	1.05
T. protein	6.4	g/dL
Alb.	3.4	g/dL	HBsAg	(−)	CLIA
T. bil.	0.3	mg/dL	Anti-HBs	(−)	CLIA
AST	42	IU/L	Anti-HBc	(+) 1.62	CLIA
ALT	45	IU/L	HBV-DNA	(−)	Real-time PCR
ALP	348	IU/L	Anti-HCV	(−)	CLIA
CHE	238	IU/L
𝛾-GTP	56	IU/L

PCR: polymerase chain reaction; CLIA: chemiluminescence immunoassay.